 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InMed Pharmaceuticals, Inc. engages in the development of cannabinoids drug design platform. Its product pipeline includes INM-750 for the treatment of epidermolysis bullosa and INM-085 for the treatment of glaucoma. The company was founded by Christopher Bogart and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

52-Wk High	$1.14
52-Wk Low	$0.30

IN Intermec, Inc.

About

Feed

News

Fundamentals